Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$16,708 Mln
P/E Ratio
39.54
P/B Ratio
1.99
Industry P/E
87.38
Debt to Equity
0.31
ROE
0.05 %
ROCE
3.77 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$5,856.23 Mln
EBITDA
$5,279.27 Mln
Net Profit
$5,589.90 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Cooper Companies Inc (COO)
| -10.55 | -1.84 | -16.52 | -7.44 | -39.59 | -22.33 | -7.62 |
BSE Sensex*
| 2.55 | 3.65 | 4.54 | 7.46 | 12.04 | 19.65 | 11.41 |
S&P Midcap 400
| -8.37 | -2.02 | -11.96 | -1.34 | 3.58 | 11.87 | 6.46 |
2024
|
2023
|
|
---|---|---|
Cooper Companies Inc (COO)
| -75.43 | 14.47 |
S&P Midcap 400
| 12.12 | 14.45 |
BSE Sensex
| 8.10 | 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
---|---|---|---|---|
107.46 | 30,681.10 | 24.51 | 21.11 | |
84.60 | 107,964.51 | 25.62 | 8.69 | |
31.33 | 2,771.88 | 20.48 | 14.33 | |
231.64 | 36,759.42 | 52.26 | 13.63 |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses... comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California. Address: 6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583 Read more
President, CEO & Non-Independent Director
Mr. Albert G. White III
President, CEO & Non-Independent Director
Mr. Albert G. White III
Headquarters
San Ramon, CA
Website
The total asset value of Cooper Companies Inc (COO) stood at $ 13,222 Mln as on 31-Jan-25
The share price of Cooper Companies Inc (COO) is $82.23 (NYSE) and $82.23 (NASDAQ) as of 29-Apr-2025 16:00 EDT. Cooper Companies Inc (COO) has given a return of -39.59% in the last 3 years.
Cooper Companies Inc (COO) has a market capitalisation of $ 16,708 Mln as on 29-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Cooper Companies Inc (COO) is 1.99 times as on 29-Apr-2025, a 45% discount to its peers’ median range of 3.59 times.
The P/E ratio of Cooper Companies Inc (COO) is 39.54 times as on 29-Apr-2025, a 55% discount to its peers’ median range of 87.38 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Cooper Companies Inc (COO) and enter the required number of quantities and click on buy to purchase the shares of Cooper Companies Inc (COO).
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California. Address: 6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583
The CEO & director of Mr. Albert G. White III. is Cooper Companies Inc (COO), and CFO & Sr. VP is Mr. Albert G. White III.
There is no promoter pledging in Cooper Companies Inc (COO).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
3,588
|
|
2,994
|
|
10,741
|
|
277
|
Cooper Companies Inc (COO) | Ratios |
---|---|
Return on equity(%)
|
5.18
|
Operating margin(%)
|
13.85
|
Net Margin(%)
|
10.57
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Cooper Companies Inc (COO) was $0 Mln.